Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luisa Solis Soto

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Genome Biology|August 8, 2025
LSGI: interpretable spatial gradient analysis for spatial transcriptomics dataQingnan Liang, Luisa Solis Soto, Cara Haymaker, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
Interpretable Spatial Gradient Analysis for Spatial Transcriptomics DataQingnan Liang, Luisa Solis Soto, Cara Haymaker, et al.
Hepatology (Baltimore, Md.)|September 12, 2021
The immunogenomic landscape of resected intrahepatic cholangiocarcinomaFernando Carapeto, Behnaz Bozorgui, Rachna T Shroff, et al.
Arxiv|December 25, 2025
From Classical Machine Learning to Emerging Foundation Models: Review on Multimodal Data Integration for Cancer ResearchAmgad Muneer, Muhammad Waqas, Maliazurina B Saad, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
CyTOF-based profiling of circulating tumor cells predicts aggressiveness and therapy response in SCLC liquid biopsies at a personalized levelMukulika Bose, Cole Ruoff, Shafqat Ehsan, et al.
Blood Advances|March 31, 2022
SIRPα+ macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximabMario L Marques-Piubelli, Edwin R Parra, Lei Feng, et al.
Cancer Innovation|July 1, 2024
Integrative genomic and transcriptomic profiling of pulmonary sarcomatoid carcinoma identifies molecular subtypes associated with distinct immune features and clinical outcomesSahil Seth, Runzhe Chen, Yang Liu, et al.
Nature Cancer|December 30, 2022
Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancerPat Gulhati, Aislyn Schalck, Shan Jiang, et al.
Cancers|March 29, 2023
Differential Spatial Gene and Protein Expression Associated with Recurrence Following Chemoradiation for Localized Anal Squamous Cell CancerSharia Hernandez, Prajnan Das, Emma B Holliday, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2024
YAP1 Status Defines Two Intrinsic Subtypes of LCNEC with Distinct Molecular Features and Therapeutic VulnerabilitiesC Allison Stewart, Lixia Diao, Yuanxin Xi, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Genome Biology|August 8, 2025
LSGI: interpretable spatial gradient analysis for spatial transcriptomics dataQingnan Liang, Luisa Solis Soto, Cara Haymaker, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
Interpretable Spatial Gradient Analysis for Spatial Transcriptomics DataQingnan Liang, Luisa Solis Soto, Cara Haymaker, et al.
Hepatology (Baltimore, Md.)|September 12, 2021
The immunogenomic landscape of resected intrahepatic cholangiocarcinomaFernando Carapeto, Behnaz Bozorgui, Rachna T Shroff, et al.
Arxiv|December 25, 2025
From Classical Machine Learning to Emerging Foundation Models: Review on Multimodal Data Integration for Cancer ResearchAmgad Muneer, Muhammad Waqas, Maliazurina B Saad, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
CyTOF-based profiling of circulating tumor cells predicts aggressiveness and therapy response in SCLC liquid biopsies at a personalized levelMukulika Bose, Cole Ruoff, Shafqat Ehsan, et al.
Blood Advances|March 31, 2022
SIRPα+ macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximabMario L Marques-Piubelli, Edwin R Parra, Lei Feng, et al.
Cancer Innovation|July 1, 2024
Integrative genomic and transcriptomic profiling of pulmonary sarcomatoid carcinoma identifies molecular subtypes associated with distinct immune features and clinical outcomesSahil Seth, Runzhe Chen, Yang Liu, et al.
Nature Cancer|December 30, 2022
Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancerPat Gulhati, Aislyn Schalck, Shan Jiang, et al.
Cancers|March 29, 2023
Differential Spatial Gene and Protein Expression Associated with Recurrence Following Chemoradiation for Localized Anal Squamous Cell CancerSharia Hernandez, Prajnan Das, Emma B Holliday, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2024
YAP1 Status Defines Two Intrinsic Subtypes of LCNEC with Distinct Molecular Features and Therapeutic VulnerabilitiesC Allison Stewart, Lixia Diao, Yuanxin Xi, et al.
Pageof 2